Donald Hackett is a Publisher at Vax-Before-Travel. He focuses on Health News, Immunology, Consumer Health, and Drugs & Medication, with a particular interest in how AI-powered solutions can enhance personalized vaccine delivery. Donald's insights and expertise have been featured in Vax-Before-Travel and the Precision Vaccines Program.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Donald Hackett's articles primarily focus on global health, disease outbreaks, vaccines, infectious diseases, and public health. His coverage heavily relies on citing data and government announcements.
Given the reliance on data and government sources in his articles, Donald may be interested in pitches that provide access to or analysis of exclusive or newly released data related to healthcare trends or government policies impacting global health. Pitches which offer insights into emerging disease outbreaks or innovative approaches to addressing public health concerns could also align well with his coverage.
It is important for potential contributors reaching out to Donald to ensure that their expertise lies within the realm of healthcare research, policy-making, epidemiology, pharmaceuticals or a related field where they can add value by providing factual information and expert commentary.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Jamaica has a Level 3 Travel advisory from the U.S. State Department
Bladder cancer therapy combined with BCG vaccine becomes available in Europe in 2026
Chikungunya dengue, malaria vaccine availability in 2026 depend on each country's regulatory agency
Fact check in progress Published December 31, 2025 SARS-CoV-2 tests include nucleic acid amplification tests and PCR tests
Fact check in progress Published January 6, 2026 Dengue vaccines are available in most endemic countries in 2026 by Denys Vitali
Fact check in progress Published April 10, 2026 Dengue vaccine unavailable in the USA in 2026 Worldwide (Vax-Before-Travel News)
Fact check in progress Published April 11, 2026 Over 10 versions of the BCG vaccine are in use in 2026 India (Vax-Before-Travel News)
Na-GST-1/Al–CpG formulation shows strongest immune response and lowest parasite burden
Fact check in progress Published April 13, 2026 Congenital Chagas is a key target within PAHO's Elimination Initiative
Fact check in progress Published April 14, 2026 PF-07307405 Lyme Disease Vaccine Candidate Shows Phase 3 Study Results
